CIBC Bancorp USA Inc. Invests $29.65 Million in Lam Research Corporation $LRCX

CIBC Bancorp USA Inc. purchased a new stake in Lam Research Corporation (NASDAQ:LRCX) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 221,433 shares of the semiconductor company’s stock, valued at approximately $29,650,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in LRCX. Stance Capital LLC bought a new position in Lam Research in the 3rd quarter valued at approximately $26,000. Howard Hughes Medical Institute acquired a new stake in Lam Research in the second quarter valued at approximately $27,000. Triumph Capital Management bought a new stake in shares of Lam Research during the third quarter worth $27,000. Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research during the second quarter worth $29,000. Finally, Delos Wealth Advisors LLC acquired a new position in shares of Lam Research during the second quarter worth $30,000. 84.61% of the stock is owned by institutional investors.

Lam Research Stock Down 0.8%

Shares of NASDAQ:LRCX opened at $224.71 on Thursday. The firm has a market cap of $280.61 billion, a P/E ratio of 46.05, a P/E/G ratio of 2.44 and a beta of 1.77. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $256.68. The business has a fifty day simple moving average of $226.06 and a 200 day simple moving average of $175.71. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business’s revenue was up 22.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be issued a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a yield of 0.5%. Lam Research’s dividend payout ratio is presently 21.31%.

Analyst Upgrades and Downgrades

LRCX has been the subject of a number of research reports. New Street Research increased their price target on Lam Research from $195.00 to $235.00 and gave the company a “neutral” rating in a research note on Friday, January 30th. Deutsche Bank Aktiengesellschaft boosted their price objective on Lam Research from $260.00 to $290.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. Argus increased their target price on Lam Research from $175.00 to $280.00 in a research report on Tuesday, February 3rd. Morgan Stanley lifted their price target on Lam Research from $244.00 to $254.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 25th. Finally, HSBC boosted their price target on Lam Research from $181.00 to $221.00 and gave the stock a “hold” rating in a report on Friday, January 30th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and an average price target of $245.35.

Insider Buying and Selling at Lam Research

In other Lam Research news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the transaction, the director owned 253,705 shares in the company, valued at approximately $57,235,848. This trade represents a 12.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares in the company, valued at $242,334,371.15. This trade represents a 4.42% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 130,886 shares of company stock valued at $29,658,802. 0.31% of the stock is currently owned by company insiders.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.